These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 25839989

  • 1. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ, Bowman BN, Anderson JR.
    Cardiol Rev; 2015; 23(4):201-11. PubMed ID: 25839989
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 3. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 4. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D, Borer JS.
    Drugs; 2007 Oct; 67 Suppl 2():15-24. PubMed ID: 17999560
    [Abstract] [Full Text] [Related]

  • 5. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Oct; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 6. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 7. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug 27; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 8. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 9. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 10. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL, Francis KE, Lowe DK, Cahoon WD.
    Ther Adv Cardiovasc Dis; 2016 Dec 29; 10(6):348-352. PubMed ID: 27659287
    [Abstract] [Full Text] [Related]

  • 11. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I, Szél T, Jaeger K, Baczkó I, Cerbai E, Romanelli MN, Gy Papp J, Varró A.
    Curr Med Chem; 2011 Dec 29; 18(24):3662-74. PubMed ID: 21774761
    [Abstract] [Full Text] [Related]

  • 12. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug 29; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 13. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M, Robertson M, Ford I, Borer JS, Komajda M, Kindermann I, Maack C, Lainscak M, Swedberg K, Tavazzi L.
    Am J Cardiol; 2015 Dec 15; 116(12):1890-7. PubMed ID: 26508709
    [Abstract] [Full Text] [Related]

  • 14. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D, Camm JA.
    Drugs; 2004 Dec 15; 64(16):1757-65. PubMed ID: 15301560
    [Abstract] [Full Text] [Related]

  • 15. The Clinical Use of Ivabradine.
    Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR.
    J Am Coll Cardiol; 2017 Oct 03; 70(14):1777-1784. PubMed ID: 28958335
    [Abstract] [Full Text] [Related]

  • 16. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I, Camm AJ.
    Adv Cardiol; 2006 Oct 03; 43():79-96. PubMed ID: 16936474
    [Abstract] [Full Text] [Related]

  • 17. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Oct 03; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 18. The biological effects of ivabradine in cardiovascular disease.
    Speranza L, Franceschelli S, Riccioni G.
    Molecules; 2012 Apr 30; 17(5):4924-35. PubMed ID: 22547315
    [Abstract] [Full Text] [Related]

  • 19. Ivabradine: A Review of Labeled and Off-Label Uses.
    Oliphant CS, Owens RE, Bolorunduro OB, Jha SK.
    Am J Cardiovasc Drugs; 2016 Oct 30; 16(5):337-47. PubMed ID: 27405864
    [Abstract] [Full Text] [Related]

  • 20. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE, Bishop BM, Mauro VF.
    Am J Ther; 2018 Oct 30; 25(2):e247-e266. PubMed ID: 26910057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.